Robert Ang, M.B.B.S
2021
In 2021, Robert Ang, M.B.B.S earned a total compensation of $1.7M as President and Chief Executive Officer at Vor Biopharma, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $218,705 |
|---|---|
| Option Awards | $919,080 |
| Salary | $507,760 |
| Other | $17,992 |
| Total | $1,663,537 |
MBBS received $919.1K in option awards, accounting for 55% of the total pay in 2021.
MBBS also received $218.7K in non-equity incentive plan, $507.8K in salary and $18K in other compensation.
Rankings
In 2021, Robert Ang, M.B.B.S' compensation ranked 6,800th out of 12,415 executives tracked by ExecPay. In other words, MBBS earned more than 45.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,800 out of 12,415 | 45th |
Division Manufacturing | 2,954 out of 5,505 | 46th |
Major group Chemicals And Allied Products | 1,306 out of 2,375 | 45th |
Industry group Drugs | 1,164 out of 2,096 | 45th |
Industry Biological Products, Except Diagnostic Substances | 275 out of 449 | 39th |
Source: SEC filing on April 28, 2022.
MBBS' colleagues
We found three more compensation records of executives who worked with Robert Ang, M.B.B.S at Vor Biopharma in 2021.